>The New Scientist is reporting the announcement (available by subscription here and the full, free version is here) by Pharmafrontiers (which is officially “Opexa Therapeutics.”) that the company has successfully de-differentiated human blood cells into stem cells that are usually thought to be from other cell lineages. In other words, Pharmafrontiers, “claims to have refined … Continue reading
The New Scientist is reporting the announcement (available by subscription here and the full, free version is here) by Pharmafrontiers (which is officially “Opexa Therapeutics.”) that the company has successfully de-differentiated human blood cells into stem cells that are usually thought to be from other cell lineages. In other words, Pharmafrontiers, “claims to have refined … Continue reading